Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10039039
rs10039039
KCNIP1
T 0.700 GeneticVariation GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150

2019
dbSNP: rs1005585
rs1005585
CBS
C 0.700 GeneticVariation GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150

2019
dbSNP: rs1015164
rs1015164
CCRL2
0.700 GeneticVariation GWASCAT Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. 26553974

2015
dbSNP: rs1015164
rs1015164
CCRL2
A 0.700 GeneticVariation GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150

2019
dbSNP: rs10173355
rs10173355
UGT1A10 ; UGT1A8 ; UGT1A7 ; UGT1A9
0.700 GeneticVariation GWASCAT Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols. 25884002

2015
dbSNP: rs10182825
rs10182825
PPP1CB ; SPDYA
A 0.700 GeneticVariation GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150

2019
dbSNP: rs1042126
rs1042126
CDSN ; PSORS1C1
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs1042134
rs1042134
CDSN ; PSORS1C1
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs1042147
rs1042147
CDSN ; PSORS1C1
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs10456057
rs10456057
HLA-B ; USP8P1
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs10467472
rs10467472
RGCC
C 0.700 GeneticVariation GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150

2019
dbSNP: rs10484554
rs10484554
HLA-B ; LOC112267902
0.700 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166

2009
dbSNP: rs10484554
rs10484554
HLA-B ; LOC112267902
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs10495970
rs10495970 		0.700 GeneticVariation GWASCAT Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384. 24554482

2014
dbSNP: rs10501678
rs10501678
GRM5
0.700 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166

2009
dbSNP: rs10509586
rs10509586
LINC01374
0.700 GeneticVariation GWASCAT Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384. 24554482

2014
dbSNP: rs1051794
rs1051794
MICA
0.700 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166

2009
dbSNP: rs1058026
rs1058026
HLA-B
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs1062470
rs1062470
CDSN ; PSORS1C1
0.700 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166

2009
dbSNP: rs10808739
rs10808739
CYP7B1
0.700 GeneticVariation GWASCAT Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. 22174851

2011
dbSNP: rs10892324
rs10892324
SLC37A4
G 0.700 GeneticVariation GWASCAT Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols. 25461247

2015
dbSNP: rs10947091
rs10947091
HCG20
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs10947095
rs10947095
HCG20
0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs10947207
rs10947207 		0.700 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598

2010
dbSNP: rs10947207
rs10947207 		0.700 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166

2009